Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17719
Country/Region: Kenya
Year: 2017
Main Partner: Pathfinder International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $9,926,262 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $200,127
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $615,894
Sexual Prevention: Other Sexual Prevention (HVOP) $1,077,370
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,429,150
Treatment: Adult Treatment (HTXS) $6,111,444
Treatment: Pediatric Treatment (PDTX) $492,277
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2018 572
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2018 105
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2018 297
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2018 51
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2018 1,420
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2018 371
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2018 1,134
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2018 165
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2018 2,036
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2018 726
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2018 1,095
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2018 195
GEND_GBV 25-49, Female, Physical and/or Emotional Violence 2018 1,287
GEND_GBV 25-49, Female, Sexual Violence (Post-Rape Care) 2018 1,064
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2018 7
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 395
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 8,462
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 2,633
GEND_GBV Number of people receiving post-GBV care 2018 11,095
HTS_TST By Key Population: FSW, Negative 2018 178
HTS_TST By Key Population: MSM, Negative 2018 598
HTS_TST By Key Population: People in prisons and other enclosed settings, Negative 2018 705
HTS_TST By Key Population: PWID, Negative 2018 44
HTS_TST By Key Population: TG, Negative 2018 33
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 342,224
HTS_TST Service Delivery Point (Facility) ANC: <1, Negative 2018 3
HTS_TST Service Delivery Point (Facility) ANC: 1-9, Negative 2018 3
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2018 26
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 1,231
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 4,265
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 6,239
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 25
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 38
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 538
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 725
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 191
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 1,055
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 767
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 800
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 767
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 2,013
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 1,002
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 68
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 68
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 1,012
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 1,003
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 138
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 93
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 100
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 94
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 305
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 145
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 8
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 8
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 2,331
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 703
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 1,908
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 1,803
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 2,667
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 1,965
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 1,931
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 1,848
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 5,149
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 3,189
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 208
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 209
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 4,124
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 91
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 62
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 63
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 61
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 219
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 90
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2018 203
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2018 1,803
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 398
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 247
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 5,011
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 3,415
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 3,470
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 3,106
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 9,406
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 6,303
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 325
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 398
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 703
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 732
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 934
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 14,091
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 7,041
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: <15, Negative 2018 3,908
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 35,771
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 29
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 44
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 476
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 221
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 3,520
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 2,962
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 39,162
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 22,135
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: Unknown Age, Male, Negative 2018 1
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 50
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative 2018 85
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 1,658
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 1,068
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 3,678
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 4,597
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 69,926
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 34,735
HTS_TST Sum of Test Result disaggregates 2018 9,639
HTS_TST_POS By Key Population: FSW, Positive 2018 26
HTS_TST_POS By Key Population: MSM, Positive 2018 26
HTS_TST_POS By Key Population: People in prisons and other enclosed settings, Positive 2018 66
HTS_TST_POS By Key Population: PWID, Positive 2018 17
HTS_TST_POS By Test Result: Positive 2018 9,639
HTS_TST_POS Service Delivery Point (Facility) ANC: 1-9, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 38
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 43
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 255
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2018 80
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 74
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 63
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 113
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 74
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 17
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 34
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 89
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 111
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 95
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 95
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 36
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 17
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 57
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2018 18
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2018 19
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 21
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 36
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 58
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 23
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 72
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 689
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 38
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 11
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 456
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 552
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: <15, Positive 2018 117
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 858
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 41
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 20
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 30
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 33
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 805
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 784
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 78
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 34
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive 2018 92
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive 2018 92
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 1,625
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 1,255
PMTCT_ART Already on ART at beginning of current pregnancy 2018 2,845
PMTCT_ART New on ART 2018 1,751
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 4,596
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 109,663
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 4,598
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 1,273
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 2,598
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 128
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 190
PMTCT_EID Unknown, <= 2 months 2018 244
PMTCT_EID Unknown, 2 - 12 months 2018 165
PMTCT_STAT By Age (Numerator): <10 2018 2
PMTCT_STAT By Age (Numerator): 10-14 2018 508
PMTCT_STAT By Age (Numerator): 15-19 2018 2,642
PMTCT_STAT By Age (Numerator): 20-24 2018 33,567
PMTCT_STAT By Age (Numerator): 25-49 2018 69,080
PMTCT_STAT By Age (Numerator): 50+ 2018 3,864
PMTCT_STAT By Number of known positives: 10-14 2018 4
PMTCT_STAT By Number of known positives: 15-19 2018 42
PMTCT_STAT By Number of known positives: 20-24 2018 811
PMTCT_STAT By Number of known positives: 25-49 2018 1,625
PMTCT_STAT By Number of known positives: 50+ 2018 93
PMTCT_STAT By Number of new negative: 10-14 2018 478
PMTCT_STAT By Number of new negative: 15-19 2018 2,229
PMTCT_STAT By Number of new negative: 20-24 2018 30,950
PMTCT_STAT By Number of new negative: 25-49 2018 66,045
PMTCT_STAT By Number of new negative: 50+ 2018 4,680
PMTCT_STAT By Number of new positives: 10-14 2018 1
PMTCT_STAT By Number of new positives: 15-19 2018 26
PMTCT_STAT By Number of new positives: 20-24 2018 644
PMTCT_STAT By Number of new positives: 25-49 2018 1,302
PMTCT_STAT By Number of new positives: 50+ 2018 72
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 109,663
PMTCT_STAT_den By Age (Denominator): <15-19 2018 2,541
PMTCT_STAT_den By Age (Denominator): 10-14 2018 501
PMTCT_STAT_den By Age (Denominator): 20-24 2018 33,446
PMTCT_STAT_den By Age (Denominator): 25-49 2018 69,372
PMTCT_STAT_den By Age (Denominator): 50+ 2018 3,860
PP_PREV Age/sex: 10-14 Female 2018 1,000
PP_PREV Age/sex: 10-14 Male 2018 1,000
PP_PREV Age/sex: 15-19 Female 2018 3,800
PP_PREV Age/sex: 15-19 Male 2018 2,613
PP_PREV Age/sex: 20-24 Female 2018 3,234
PP_PREV Age/sex: 20-24 Male 2018 2,300
PP_PREV Age/sex: 25-49 Female 2018 200
PP_PREV Age/sex: 25-49 Male 2018 500
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 14,647
PP_PREV Sum of Age/Sex disaggregates 2018 14,647
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 40
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 725
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 44
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 811
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,627
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 1,621
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 42
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 725
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 45
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 813
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 146
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,064
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 66
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 525
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 5,323
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 5,639
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 146
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,088
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 66
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 546
TX_CURR Age/Sex: <1 2018 9
TX_CURR Age/Sex: <1-9 2018 192
TX_CURR Age/Sex: 10-14 Female 2018 302
TX_CURR Age/Sex: 10-14 Male 2018 188
TX_CURR Age/Sex: 15-19 Female 2018 592
TX_CURR Age/Sex: 15-19 Male 2018 499
TX_CURR Age/Sex: 20-24 Female 2018 3,679
TX_CURR Age/Sex: 20-24 Male 2018 1,716
TX_CURR Age/Sex: 25-49 Female 2018 8,630
TX_CURR Age/Sex: 25-49 Male 2018 3,975
TX_CURR Age/Sex: 50+ Female 2018 595
TX_CURR Age/Sex: 50+ Male 2018 375
TX_CURR Aggregated Age/Sex: <15 Female 2018 1,751
TX_CURR Aggregated Age/Sex: <15 Male 2018 1,526
TX_CURR Aggregated Age/Sex: 15+ Female 2018 20,891
TX_CURR Aggregated Age/Sex: 15+ Male 2018 10,567
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 55,487
TX_CURR Sum of age/sex disaggregates 2018 1,091
TX_CURR Sum of Aggregated Age/Sex <15 2018 3,277
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 31,458
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 34,735
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 399
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 223
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 4,379
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,929
TX_NEW By Age/Sex: <1 2018 34
TX_NEW By Age/Sex: 1-9 2018 87
TX_NEW By Age/Sex: 10-14 Female 2018 91
TX_NEW By Age/Sex: 10-14 Male 2018 81
TX_NEW By Age/Sex: 15-19 Female 2018 73
TX_NEW By Age/Sex: 15-19 Male 2018 55
TX_NEW By Age/Sex: 20-24 Female 2018 327
TX_NEW By Age/Sex: 20-24 Male 2018 149
TX_NEW By Age/Sex: 25-49 Female 2018 847
TX_NEW By Age/Sex: 25-49 Male 2018 345
TX_NEW By Age/Sex: 50+ Female 2018 55
TX_NEW By Age/Sex: 50+ Male 2018 36
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 9,096
TX_NEW Sum of Age/Sex disaggregates 2018 2,059
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 6,930
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 55,425
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 48,108
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,840
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,754
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 29,388
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 15,120
TX_PVLS Numerator: Indication: Routine 2018 48,108
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 384
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2,293
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 2,091
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 34,261
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 16,748
TX_PVLS_den Denominator: Indication: Routine 2018 50,356
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 453
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 328
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 4,888
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,159
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 7,829
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 8,680
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 507
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 356
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 5,444
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,373
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 56,074
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 644
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 13
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 15
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 298
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 317
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 1,399
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 1,460
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 33,833
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 19,348
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 10,469
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 29
TX_TB_den Denominator: By Screen Result: Negative 2018 43,097
TX_TB_den Denominator: By Screen Result: Positive 2018 11,686
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 14,759
Cross Cutting Budget Categories and Known Amounts Total: $140,088
Gender: Gender Based Violence (GBV) $140,088
GBV Prevention
Implementation
Monitoring and Evaluation
Post GBV Care
Implementation
Monitoring and Evaluation